{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:27:46Z","timestamp":1777566466438,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijantimicag.2012.07.005","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T19:15:30Z","timestamp":1348168530000},"page":"423-426","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors for anti-MRSA drug resistance"],"prefix":"10.1016","volume":"40","author":[{"given":"Yasuhisa","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/JCM.02311-06","article-title":"Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection","volume":"45","author":"Davis","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/QCO.0b013e3283509cfa","article-title":"New therapy options for MRSA with respiratory infection\/pneumonia","volume":"25","author":"Ramirez","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/CCM.0b013e3181eb3b96","article-title":"Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis","volume":"38","author":"Kalil","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0b013e31821109ec","article-title":"Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","author":"Culos","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0025","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1185\/03007990903512057","article-title":"The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid","volume":"26","author":"Stein","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1413-8670(11)70223-9","article-title":"Length of exposure to the hospital environment is more important than antibiotic exposure in healthcare associated infections by methicillin-resistant Staphylococcus aureus: a comparative study","volume":"15","author":"Baraboutis","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0040","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 5th ed. Document M7-A5. Wayne, PA: CLSI; 2001."},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0045","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0050","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2672.2006.02932.x","article-title":"Development of a rapid strain differentiation method for methicillin-resistant Staphylococcus aureus isolated in Japan by detecting phage-derived open-reading frames","volume":"101","author":"Suzuki","year":"2006","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0055","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/00029330-200809010-00003","article-title":"Characterization of multidrug-resistant and metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China","volume":"121","author":"Dong","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/QCO.0b013e328301391d","article-title":"New approaches to prevention of staphylococcal infection in surgery","volume":"21","author":"van Rijen","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0065","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/S0950268811000641","article-title":"Clinical significance of methicillin-resistant Staphylococcus aureus colonization in residents in community long-term-care facilities in Spain","volume":"140","author":"Manzur","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1466-7657.2010.00833.x","article-title":"MRSA\u2013\u2013global threat and personal disaster: patients\u2019 experiences","volume":"58","author":"Anderson","year":"2011","journal-title":"Int Nurs Rev"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0075","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.ijid.2010.09.013","article-title":"Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK","volume":"15","author":"Lewis","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.ccx.0000176690.18433.22","article-title":"New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient","volume":"11","author":"Schmidt-Ioanas","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0085","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/429906","article-title":"Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area","volume":"40","author":"Eguia","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0090","first-page":"568","article-title":"Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management","volume":"20","author":"Lewis","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0095","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2174\/138161208784980608","article-title":"New developments in antimicrobial use in sepsis","volume":"14","author":"Kaul","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diagmicrobio.2011.11.010","article-title":"Antimicrobial susceptibility and molecular characteristics of 857 methicillin-resistant Staphylococcus aureus isolates from 16 medical centers in Japan (2008\u20132009): nationwide survey of community-acquired and nosocomial MRSA","volume":"72","author":"Yanagihara","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0105","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/502593","article-title":"Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia","volume":"26","author":"Ernst","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/606027","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance","volume":"200","author":"Bae","year":"2009","journal-title":"J Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2012.07.005_bib0115","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1086\/519473","article-title":"Epidemiology of staphylococcal resistance","volume":"45","author":"Shorr","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1469-0691.2006.01550.x","article-title":"Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002\u20132004)","volume":"12","author":"Sader","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0125","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/JCM.02144-10","article-title":"Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus","volume":"49","author":"Watanabe","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2012.07.005_bib0130","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1128\/AAC.01613-07","article-title":"Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus","volume":"52","author":"Howden","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791200310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791200310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T23:24:16Z","timestamp":1562196256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791200310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S092485791200310X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.07.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}